Renaissance Technologies - FORMA THERAPEUTICS HLDGS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$13,967,000
+104.0%
700,100
-29.5%
0.02%
+150.0%
Q2 2022$6,847,000
+15.0%
993,732
+55.2%
0.01%
+14.3%
Q1 2022$5,954,000
+23.9%
640,200
+89.5%
0.01%
+16.7%
Q4 2021$4,805,000
+153.0%
337,900
+312.6%
0.01%
+200.0%
Q3 2021$1,899,00081,9000.00%
Other shareholders
FORMA THERAPEUTICS HLDGS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,565,526$36,305,0005.70%
Cormorant Asset Management, LP 4,720,495$109,468,0004.45%
Logos Global Management LP 2,115,000$49,047,0003.54%
RA Capital Management 9,011,651$208,980,0002.90%
Opaleye Management Inc. 182,950$4,243,0000.79%
Artal Group S.A. 1,000,000$23,190,0000.52%
HighVista Strategies LLC 26,711$619,0000.41%
Integral Health Asset Management, LLC 60,000$1,391,0000.40%
HHLR ADVISORS, LTD. 1,100,000$25,509,0000.33%
Baker Brothers Advisors 2,024,876$46,957,0000.21%
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders